PUBLIC HEALTH SERVICE Sample Clauses

PUBLIC HEALTH SERVICE. PATENT LICENSE AGREEMENT – EXCLUSIVE This Agreement is based on the model Patent License Exclusive Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), and the Food and Drug Administration (“FDA”), which are agencies of the PHS within the Department of Health and Human Services (“HHS”). This Cover Page identifies the Parties to this Agreement: The U.S. Department of Health and Human Services, as represented by The National Cancer Institute an Institute or Center (hereinafter referred to as the “IC”) of the NIH and Senti Biosciences, Inc., hereinafter referred to as the “Licensee”, having offices at 0 Xxxxxxxxx Xx., Xxxxx Xxxxx, Xxxxx Xxx Xxxxxxxxx, XX 00000, And operating under the laws of Delaware. Tax ID No.: 00-0000000 For the IC internal use only: License Number: License Application Number: [***] Serial Number(s) of Licensed Patent(s) or Patent Application(s):
AutoNDA by SimpleDocs
PUBLIC HEALTH SERVICE. Seller will calculate and submit the Q4 2012 PHS covered entity pricing and Q1 2013 PHS covered entity pricing. Purchaser will add the product to the price list upon Closing and Seller will delete the product effective October 1, 2012.
PUBLIC HEALTH SERVICE. PATENT LICENSE AGREEMENT NONEXCLUSIVE SUBLICENSABLE This Agreement is based on the model Patent License Non-Exclusive Sublicensable Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), and the Food and Drug Administration (“FDA”), which are agencies of the PHS within the Department of Health and Human Services (“HHS”). This Cover Page identifies the Parties to this Agreement: The U.S. Department of Health and Human Services, as represented by The National Heart, Lung, and Blood Institute (NHLBI) an Institute or Center (hereinafter referred to as the “IC”) of the NIH and Torus Therapeutics, Inc., hereinafter referred to as the “Licensee”, having offices at 000 Xxxxxxxxxx Xxxxxx, Xxxxxxxxx, XX 00000, created and operating under the laws of the State of Delaware, United States of America Tax ID No.: 000000000 For the IC’s internal use only License Number: L-124-2017/0 License Application Number: A-084-2017 Serial Number(s) of Licensed Patent(s) or Patent Application(s): O/Ref Country Application N° Status [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] All entitled: [**]. HHS Reference: E-241-2010 Licensee: Torus Therapeutics Cooperative Research and Development Agreement (CRADA) Number (if a subject invention): N/A Additional Remarks: N/A Public Benefit(s): Development of Gene Therapy Products This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D 15A-084-2017; L-1242017/0 CONFIDENTIAL NIH Patent License Agreement Nonexclusive – Sublicensable Model 10-2015 ((Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options. The IC and the Licensee agree as follows:
PUBLIC HEALTH SERVICE. 7. Asset Purchase Agreement dated December 2, 1996 between Connetics and SKB
PUBLIC HEALTH SERVICE. PITS INTERINSTITUTIONAL AGREEMENT
PUBLIC HEALTH SERVICE. If the Recipient does not have an assurance and will be utilizing a subcontractor to perform the animal work, then the Recipient and subcontractor must have an Inter- Institutional Assurance in place to allow the Recipient to utilize the assurance of the subcontractor to meet the Government's requirements for assurance. The request for this negotiation of this assurance must be submitted to OLAW by the Government on behalf of the Recipient.
PUBLIC HEALTH SERVICE. If the Recipient does not have an assurance and will be utilizing a Sub-recipient to perform the animal work then the Recipient and Sub- recipient must have an Inter-Institutional Assurance in place to allow the Recipient to utilize the assurance of the Sub-recipient to meet the DHHS requirements for assurance. The request for this negotiation of this assurance must be submitted to OLAW by BARDA on behalf of the Recipient. The PHS Policy requires that Assured institutions base their programs of animal care and use on the Guide for the Care and Use of Laboratory Animals http://www.nap.edu/readingroom/books/labxxxx/ xxx xxxx xxxx xxxxxx with the regulations (9 CFR, Subchapter A) http://awic.nal.usda.gov/final-rules-anixxx-xxxxxxx-0-xxx-xxxxx-0-2-and-3 issued by the USDA under the Animal Welfare Act. The Guide may differ from USDA regulations in some respects. Compliance with the USDA regulations is an absolute requirement of this Policy. The Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) http://www.aaalac.org is a professional xxxxxxxxxxxx xxxx xxxpects and evaluates programs of animal care for institutions at their request. Those that meet the high standards are given the accredited status. As of the 2002 revision of the PHS Policy, the only accrediting body recognized by PHS is the AAALAC. While AAALAC accreditation is not required to conduct biomedical research, it is highly desirable. AAALAC uses the Guide as their primary evaluation tool. They also use the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. It is published by the Federated of Animal Science Societies http://www.fass.org.
AutoNDA by SimpleDocs
PUBLIC HEALTH SERVICE. NON-EXCLUSIVE PATENT and BIOLOGICAL MATERIALS LICENSE AGREEMENT FOR INTERNAL RESEARCH USE This Agreement is based on the model Non-Exclusive Patent Internal Use Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), and the Food and Drug Administration (“FDA”), which are agencies of the PHS within the Department of Health and Human Services (“HHS”). This Cover Page identifies the Parties to this Agreement: The U.S. Department of Health and Human Services, as represented by National Institute of Allergy and Infectious Diseases, an Institute or Center (hereinafter referred to as the “IC”) of the NIH and GeoVax Inc., hereinafter referred to as the “Licensee”, having offices at 1000 Xxxx Xxxx Xx., Xxx.000, Xxxxxx, Xxxxxxx 00000, created and operating under the laws of Georgia, United States of America. Tax ID No. : 50-0000000 For IC’s internal use only: License Number: L-243-2020-0 License Application Number: A-411-2020 Serial Number(s) of Licensed Patent(s) or Patent Application(s): Appendix A Cooperative Research and Development Agreement (CRADA) Number (if a subject invention): N/A Additional Remarks: N/A Public Benefit(s): Novel therapeutics may be developed using a recombinant MVA platform. This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Licensed Products, Processes, Territory, Field of Use and Termination), Appendix C (Royalties), and Appendix D (Royalty Payment Options). The IC and the Licensee agree as follows:

Related to PUBLIC HEALTH SERVICE

  • Public Health Public Health activities and reporting to the extent permitted by Applicable Law.

  • Health Services At the time of employment and subject to (b) above, full credit for registered professional nursing experience in a school program shall be given. Full credit for registered professional nursing experience may be given, subject to approval by the Human Resources Division. Non-degree nurses shall be placed on the BA Track of the Teachers Salary Schedule and shall be ineligible for movement to any other track.

  • Mental Health Services This agreement covers medically necessary services for the treatment of mental health disorders in a general or specialty hospital or outpatient facilities that are: • reviewed and approved by us; and • licensed under the laws of the State of Rhode Island or by the state in which the facility is located as a general or specialty hospital or outpatient facility. We review network and non-network programs, hospitals and inpatient facilities, and the specific services provided to decide whether a preauthorization, hospital or inpatient facility, or specific services rendered meets our program requirements, content and criteria. If our program content and criteria are not met, the services are not covered under this agreement. Our program content and criteria are defined below.

  • Behavioral Health Services Behavioral health services include the evaluation, management, and treatment for a mental health or substance use disorder condition. For the purpose of this plan, substance use disorder does not include addiction to or abuse of tobacco and/or caffeine. Mental health or substance use disorders are those that are listed in the most updated volume of either: • the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association; or • the International Classification of Disease Manual (ICD) published by the World Health Organization. This plan provides parity in benefits for behavioral healthcare services. Please see Section 10 for additional information regarding behavioral healthcare parity. Inpatient This plan covers behavioral health services if you are inpatient at a general or specialty hospital. See Inpatient Services in Section 3 for additional information. Residential Treatment Facility This plan covers services at behavioral health residential treatment facilities, which provide: • clinical treatment; • medication evaluation management; and • 24-hour on site availability of health professional staff, as required by licensing regulations. Intermediate Care Services This plan covers intermediate care services, which are facility-based programs that are: • more intensive than traditional outpatient services; • less intensive than 24-hour inpatient hospital or residential treatment facility services; and • used as a step down from a higher level of care; or • used a step-up from standard care level of care. Intermediate care services include the following: • Partial Hospital Program (PHP) – PHPs are structured and medically supervised day, evening, or nighttime treatment programs providing individualized treatment plans. A PHP typically runs for five hours a day, five days per week. • Intensive Outpatient Program (IOP) – An IOP provides substantial clinical support for patients who are either in transition from a higher level of care or at risk for admission to a higher level of care. An IOP typically runs for three hours per day, three days per week.

  • Health & Safety (a) The Employer and the Union agree that they mutually desire to maintain standards of safety and health in the Home, in order to prevent injury and illness and abide by the Occupational Health and Safety Act as amended from time to time.

  • Public Hearings If public hearings on the scope of work are held during the period of the Agreement, Contractor will make available to testify the personnel assigned to this Agreement. The Energy Commission will reimburse Contractor for compensation and travel of the personnel at the Agreement rates for the testimony which the Energy Commission requests.

  • Public Hearing 7. In the course of each proceeding, the competent investigating authority shall:

  • Occupational Health & Safety (a) It is a mutual interest of the parties to promote health and safety in workplaces and to prevent and reduce the occurrence of workplace injuries and occupational diseases. The parties agree that health and safety is of the utmost importance and agree to promote health and safety and wellness throughout the organization. The employer shall provide orientation and training in health and safety to new and current employees on an ongoing basis, and employees shall attend required health and safety training sessions. Accordingly, the parties fully endorse the responsibilities of employer and employee under the Occupational Health and Safety Act, making particular reference to the following:

  • Health Promotion and Health Education Both parties to this Agreement recognize the value and importance of health promotion and health education programs. Such programs can assist employees and their dependents to maintain and enhance their health, and to make appropriate use of the health care system. To work toward these goals:

  • Home Health Care This plan covers the following home care services when provided by a certified home healthcare agency: • nursing services; • services of a home health aide; • visits from a social worker; • medical supplies; and • physical, occupational and speech therapy.

Time is Money Join Law Insider Premium to draft better contracts faster.